Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A 52 week high is $9.85 as of September 17, 2025.
What is the 52-week low for Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A 52 week low is $4.72 as of September 17, 2025.
What is Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A stock price today?
Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A stock price today is $8.47.
What was Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A stock price yesterday?
Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A stock price yesterday was $8.86.
What is the 50-day moving average of Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A 50-day moving average is $7.88.